SCHEMBL20353496

SCHEMBL20353496

Cc1ccc(N)c(NCC(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ CYP3A4 P08684 3/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ THRB P10828 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.36
▸ MAPT P10636 4/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ PKM P14618 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ BACE1 P56817 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ KAT2B Q92831 1/20 0.34
▸ CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18235928 0.81 GUCY1A1 (0.45) CYP3A4TP53LMNAALDH1A1MAPT
SCHEMBL21310774 0.81 SMN1; SMN2 (0.41) SMN1; SMN2TDP1CYP3A4ALOX15TP53
SCHEMBL15337816 0.80 ALDH1A1 (0.42) LMNAALDH1A1BACE1FFAR4GAA
SCHEMBL17678181 0.79 LMNA (0.39) LMNAALDH1A1MAPTBACE1FFAR4
SCHEMBL2014730 0.77 LMNA (0.50) SMN1; SMN2TDP1CYP3A4ALOX15TP53
SCHEMBL18235935 0.76 KDM4E (0.43) LMNAMAPTMAPK1BACE1GAA
SCHEMBL26378132 0.75 KDM4E (0.47) SMN1; SMN2TP53LMNAALDH1A1MAPT
SCHEMBL20337678 0.75 KDM4E (0.40) LMNAALDH1A1KAT2BGAA
SCHEMBL3634658 0.74 TDP1 (0.45) SMN1; SMN2TDP1CYP3A4ALOX15TP53
SCHEMBL17263168 0.73 KAT2B (0.59) CYP3A4ALDH1A1MAPTMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018125799-A2 METALLOENZYME INHIBITOR COMPOUNDS VIAMET PHARMACEUTICALS (BERMUDA), LTD. (BM) 2018-07-05 — — WO disclosed
Send feedback